Mrs. Kelly Dunlap Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1797 King Ave, Kings Mills, OH 45034 Phone: 513-398-8050 |
Felicia Roush Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1797 King Ave, Kings Mills, OH 45034 Phone: 513-398-8050 |
Kathryn Wells Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8471 Columbia Rd, Kings Mills, OH 45034 Phone: 513-398-8050 Fax: 513-683-8367 |
Michele Foster Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1797 King Ave, Kings Mills, OH 45034 Phone: 513-398-8050 |
Sara Legault, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1826 Church St, Kings Mills, OH 45034 Phone: 513-633-1303 |
Shannon Williamson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1797 King Ave, Kings Mills, OH 45034 Phone: 513-398-8050 |
Cheryl Hahn Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5500 Columbia Rd, Kings Mills, OH 45034 Phone: 513-398-8050 |
News Archive
Researchers in Europe and the United States have demonstrated the potential of the influenza drug enisamium as a treatment for infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
Research led by T. Cooper Woods, PhD, Assistant Professor of Pharmacology and Experimental Therapeutics at LSU Health Sciences Center New Orleans, and Director of the Molecular Cardiology Research Laboratory at Ochsner Clinic Foundation, has identified the mechanism of how a drug commonly used on stents to prevent reclosure of coronary arteries, regulates cell movement which is critical to wound healing and the progression of diseases like cancer.
A team of scientists from the United Kingdom has revealed that markers of endothelial cell injury are associated with severe and fatal outcome of coronavirus disease 2019 (COVID-19). The study is currently available on the medRxiv* preprint server.
A recent study seeks to investigate the characteristics of individuals with breakthrough infections post-vaccination in North Carolina, USA.
Heme oxygenase-1 is essential for the growth of blood vessels in the placenta and in establishing blood flow in the umbilical cord. Too little HO-1 can lead to a restriction in the growth of the fetus and even in fetal death and miscarriage. New research published in BioMed Central's open access journal Medical Gas Research has shown that low dose carbon monoxide therapy is able to restore placental function and prevent fetal death in mice, without any detrimental effects.
› Verified 5 days ago